Joint Formulary & PAD

Canagliflozin/metformin - Diabetes Mellitus

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important
Empagliflozin is the preferred SGLT2.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Canagliflozin/metformin
Indication :
Diabetes Mellitus
Group Name :
Keywords :
SGLT2
Brand Names Include :
Vokanamet
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Canagliflozin/metformin is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Diabetes Mellitus.

Committee Recommendations (0)

  • No records returned.